ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome…
May 12, 2026 20:29 ET | Source: Global Medical Response LEWISVILLE, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- GMR Solutions…
Aurora, CO, May 12, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…
Aurora, CO, May 12, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…
Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with a single‑assay design, intended to rule in and…
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2026 Update: Tecan on track…
May 11, 2026 23:00 ET | Source: Rapid Nutrition Plc LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC…
May 11, 2026 04:30 ET | Source: Alvotech Company remains on track for BLA resubmissions in the second quarter REYKJAVIK,…
May 11, 2026 04:00 ET | Source: ENA Respiratory MELBOURNE, Australia, May 11, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a…
BASEL, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotechnology company focused on reprogramming the immune system…